Target intelligence / Profile preview

Coenzyme A biosynthesis enzymes

Molecular classification
Enzyme, Metabolic enzyme
01

Overview

Coenzyme A biosynthesis enzymes are a group of evolutionarily conserved enzymes responsible for the multi-step conversion of pantothenate (vitamin B5), cysteine, and ATP into coenzyme A, a central metabolic cofactor. The canonical pathway in humans and many organisms involves five steps, each catalyzed by a distinct enzyme: pantothenate kinase (PanK), phosphopantothenoylcysteine synthetase (PPCS), phosphopantothenoylcysteine decarboxylase (PPCDC), phosphopantetheine adenylyltransferase (PPAT, part of COASY in mammals), and dephospho-CoA kinase (DPCK, also part of COASY). CoA is vital for a wide range of metabolic pathways including fatty acid synthesis and degradation, energy production, and posttranslational protein modification. Genetic defects in these enzymes cause rare but severe neurodegenerative and cardiac diseases in humans. These enzymes are also validated or putative targets for antimicrobial drug development due to significant differences between microbial and human forms.

Other names
CoA biosynthetic enzymesenzymes of CoA biosynthesis pathwayCoA synthesis enzymes
02

Mechanism of action

Enzyme inhibition (blocking one or more steps in CoA biosynthesis arrests organismal or cellular function, mainly in pathogens); Antimetabolite competition with pantothenate

03

Biological functions

Cellular metabolismEnergy productionFatty acid synthesis and degradationTricarboxylic acid (TCA) cycle operationAcyl group transferProtein modification (e.g., phosphopantetheinylation)Regulation of autophagy, cell growth, cell death, signal transduction, epigenetics, and gene expression
04

Disease associations

Neurodegenerative disease (e.g., NBIA, PKAN, CoPAN)Cardiomyopathy (with mutations in biosynthetic enzymes)Infection (antimicrobial drug targets in pathogens)Cancer (due to role in cell growth, metabolism, and proliferation)
05

Safety considerations

Non-selectivity may disrupt essential metabolism in host (potential toxicity)Essential role in energy and lipid metabolism may lead to multi-organ dysfunction if inhibited in non-target organisms
06

Interacting drugs

Pantothenate analogs (antimetabolites, experimental)

1 more in the full profile.

07

Biomarkers

Levels of CoA or intermediates (such as 4′-phosphopantothenate, dephospho-CoA, 4′-phosphopantetheine) in blood or tissueGenetic variants in PANK2, PPCS, PPCDC, COASY for neurodegenerative diseases

Beyond the preview

Go deeper on Coenzyme A biosynthesis enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coenzyme A biosynthesis enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call